United States Home Healthcare Devices Market to Hit $24.68 Billion by 2033, Driven by Remote Patient Monitoring & Aging Population

Leander, Texas, United States - Nov.20.2025
As per DataM intelligence research report"The Global Home Healthcare Devices Market reached US$46.25 billion in 2024 and is expected to reach US$82.27 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033". Digital health adoption and remote monitoring trends are boosting growth of home healthcare devices.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/home-healthcare-devices-market?sp

United States: Recent Industry Developments

✅ In November 2025, Philips Healthcare launched a new connected home vital-sign monitoring system that integrates blood pressure, oxygen saturation, and heart rate data into telehealth platforms. The system enhances remote patient monitoring and early intervention. This development reinforces Philips' leadership in U.S. home healthcare technology.

✅ In October 2025, ResMed invested US$25 million to expand production of portable sleep apnea and respiratory care devices for home use, including smart CPAP units with cloud-based adherence monitoring. The expansion addresses rising demand from remote and chronic care patients. This investment strengthens ResMed's footprint in the U.S. home respiratory care market.

✅ In September 2025, Medtronic introduced next-generation insulin pumps and continuous glucose monitoring (CGM) devices designed for home use, featuring AI-driven predictive alerts and smartphone integration. The devices improve diabetes management and patient independence. This highlights Medtronic's focus on patient-centric home healthcare solutions.

✅ In August 2025, iRhythm Technologies rolled out its wearable cardiac monitoring patch for extended home arrhythmia detection, enabling long-term, real-time ECG tracking. The device reduces hospital visits while improving diagnosis accuracy. This innovation strengthens the U.S. home cardiac monitoring ecosystem.

Japan: Recent Industry Developments

✅ In November 2025, Omron Healthcare Japan launched a smart blood pressure and wellness monitoring system integrated with AI-driven health insights for home users. The system provides automated recommendations for lifestyle adjustments and alerts for abnormal readings. This reinforces Omron's leadership in Japan's home health monitoring segment.

✅ In October 2025, Terumo Corporation invested ¥2.7 billion to expand production and R&D for home-based infusion and insulin delivery devices. The move addresses growing demand from aging populations and chronic disease patients. This investment strengthens Terumo's position in Japan's home healthcare market.

✅ In September 2025, Panasonic Healthcare Japan introduced connected respiratory care devices for COPD and asthma patients, integrating inhaler usage tracking with smartphone apps for treatment adherence. The initiative improves patient outcomes through remote monitoring. This underscores Panasonic's focus on smart home healthcare technologies.

✅ In August 2025, Fujifilm Healthcare Japan rolled out a portable, home-use ultrasound system designed for telehealth applications in rural and remote areas. The device allows clinicians to perform remote diagnostics while reducing hospital visits. This development enhances Japan's home-based diagnostic healthcare capabilities.

Home Healthcare Devices Market: Drivers

The home healthcare devices market is witnessing rapid growth as consumers increasingly seek convenient, remote, and patient-centric healthcare solutions. These devices, including blood pressure monitors, glucose meters, pulse oximeters, wearable ECG monitors, and telehealth-enabled equipment, allow patients to monitor their health from home and support chronic disease management, elderly care, and post-operative recovery. Rising prevalence of chronic illnesses, an aging population, and growing focus on preventive healthcare are driving adoption. Technological advancements in wireless connectivity, IoT integration, AI-driven analytics, and mobile health applications are enhancing device functionality, real-time monitoring, and personalized care. Additionally, increasing awareness of at-home healthcare benefits and remote patient monitoring programs is supporting market growth.

Healthcare providers, insurance companies, and technology developers are increasingly collaborating to expand home healthcare device availability and ensure regulatory compliance, safety, and accuracy. Innovations in compact, user-friendly, and multi-functional devices are making home monitoring more accessible and effective. Growing adoption of telemedicine and virtual care platforms is further boosting demand for connected healthcare devices. The emphasis on reducing hospital visits, lowering healthcare costs, and improving patient engagement is encouraging wider use of home-based monitoring solutions. With technological advancements, rising health awareness, and supportive policies, the home healthcare devices market is poised for sustained global expansion.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/home-healthcare-devices-market?sp

Home Healthcare Devices Market: Major Players

Invacare Corporation, Karman Healthcare Inc., Ottobock, Pride Mobility Products Corp., Medtronic, Sunrise Medical, Meyra GmbH, Koninklijke Philips N.V., Nihon Kohden Corporation, Danaher Corporation among others.

Segment Covered in the Home Healthcare Devices Market:

By Therapeutic Devices
Insulin delivery systems dominate with 36% share, driven by rising diabetes prevalence and adoption of advanced pens and pumps for home management. Home dialysis machines hold 28%, supported by growing renal failure cases and preference for at-home treatment. Respiratory devices account for 24%, fueled by increasing COPD, asthma, and post-COVID respiratory care needs. Other therapeutic devices collectively capture 12%, addressing various chronic and post-acute conditions.

By Monitoring Devices
Blood glucose meters lead with 38% share, driven by continuous diabetes monitoring requirements and widespread home-use adoption. Blood pressure monitors hold 27%, supported by rising hypertension cases and remote patient monitoring trends. Pulse oximeters and temperature monitoring devices together account for 25%, boosted by home-based vital monitoring. Other monitoring tools represent 10%, used for broader preventive and chronic care applications.

By Mobility Care Devices
Wheelchairs dominate with 41% share, driven by aging populations, disability cases, and increased demand for electric models. Walkers hold 29%, supported by rehabilitation needs and post-operative mobility support. Mobility scooters account for 21%, driven by lifestyle convenience and enhanced autonomy for elderly users. Other mobility care devices capture 9%, used across long-term care and home-based recovery.

By Distribution Channel
Retail pharmacies lead with 44% share, offering easy access to monitoring devices, mobility aids, and consumables for chronic disease management. Hospital pharmacies hold 33%, driven by discharge prescriptions and home-care transition programs. Online pharmacies account for 23%, supported by rising e-commerce adoption, home delivery convenience, and expanding digital health platforms. Remote monitoring trends further boost online channel growth.

Regional Analysis

North America - 38% Share
North America leads with 38%, driven by high chronic disease burden, advanced home-care infrastructure, and strong adoption of remote monitoring devices. The U.S. dominates with strong insurance coverage and growing preference for home-based treatment. Technological innovation elevates device performance. Aging demographics accelerate demand.

Europe - 30% Share
Europe holds 30%, supported by structured elderly-care programs and strong uptake of mobility and monitoring devices. Germany, France, and the U.K. drive advanced home-care adoption. Chronic disease prevention initiatives improve monitoring device penetration. Government reimbursement strengthens market maturity.

Asia-Pacific - 26% Share
Asia-Pacific accounts for 26%, driven by expanding home healthcare awareness, large diabetic population, and increasing investment in home-based respiratory and dialysis devices. China, Japan, India, and South Korea lead demand. Rapid urbanization boosts remote monitoring adoption. Affordability of medical devices enhances penetration.

South America - 3% Share
South America holds 3%, with Brazil, Argentina, and Chile driving growth in chronic disease management and mobility support. Economic limitations affect uptake of advanced therapeutic devices. Public-health initiatives support increased monitoring device adoption. Gradual digital-health expansion improves accessibility.

Middle East & Africa - 3% Share
The Middle East & Africa account for 3%, led by GCC countries adopting respiratory and mobility devices for aging and chronic patients. Urban regions show rising demand for home monitoring tools. Limited infrastructure restricts broad adoption across Africa. Growing private healthcare investment moderately boosts market growth.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=home-healthcare-devices-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.